BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8502482)

  • 1. The cdk2 kinase is required for the G1-to-S transition in mammalian cells.
    Tsai LH; Lees E; Faha B; Harlow E; Riabowol K
    Oncogene; 1993 Jun; 8(6):1593-602. PubMed ID: 8502482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of the synthesis and activity of the major cyclin-dependent kinases, p34cdc2, p33cdk2, and p34cdk4, during cell cycle entry and progression in normal human T lymphocytes.
    Lucas JJ; Szepesi A; Domenico J; Tordai A; Terada N; Gelfand EW
    J Cell Physiol; 1995 Nov; 165(2):406-16. PubMed ID: 7593219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
    Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
    Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and activation of cdks (1 and 2) and cyclins in the cell cycle progression during liver regeneration.
    Loyer P; Glaise D; Cariou S; Baffet G; Meijer L; Guguen-Guillouzo C
    J Biol Chem; 1994 Jan; 269(4):2491-500. PubMed ID: 8300575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p55Cdc/cdc20 overexpression promotes early g1/s transition in myeloid cells.
    Lin ML; Sakamoto KM
    Stem Cells; 2001; 19(3):205-11. PubMed ID: 11359945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin inhibition of interleukin-2-dependent p33cdk2 and p34cdc2 kinase activation in T lymphocytes.
    Morice WG; Wiederrecht G; Brunn GJ; Siekierka JJ; Abraham RT
    J Biol Chem; 1993 Oct; 268(30):22737-45. PubMed ID: 8226784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and subcellular localization of CDK2 and cdc2 kinases and their common partner cyclin A in thyroid epithelial cells: comparison of cyclic AMP-dependent and -independent cell cycles.
    Baptist M; Lamy F; Gannon J; Hunt T; Dumont JE; Roger PP
    J Cell Physiol; 1996 Feb; 166(2):256-73. PubMed ID: 8591985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of G1 phase cyclin dependent kinases by transforming growth factor beta 1.
    Reddy KB; Hocevar BA; Howe PH
    J Cell Biochem; 1994 Nov; 56(3):418-25. PubMed ID: 7876335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal regulation of cyclin A-p107 and p33cdk2 complexes binding to a human thymidine kinase promoter element important for G1-S phase transcriptional regulation.
    Li LJ; Naeve GS; Lee AS
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3554-8. PubMed ID: 8475104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum starved v-mos-transformed cells are unable to appropriately downregulate cyclins and CDKs.
    Rhodes N; Innes CL; Propst F; Paules RS
    Oncogene; 1997 Jun; 14(25):3017-27. PubMed ID: 9223665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the role of G1/S cell cycle mediators in cellular senescence.
    Afshari CA; Vojta PJ; Annab LA; Futreal PA; Willard TB; Barrett JC
    Exp Cell Res; 1993 Dec; 209(2):231-7. PubMed ID: 8262140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase.
    Tsai LH; Harlow E; Meyerson M
    Nature; 1991 Sep; 353(6340):174-7. PubMed ID: 1653904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
    Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The differential catalytic activity of alternatively spliced cdk2 alpha and cdk2 beta in the G1/S transition and early S phase.
    Kwon TK; Buchholz MA; Jun DY; Kim YH; Nordin AA
    Exp Cell Res; 1998 Jan; 238(1):128-35. PubMed ID: 9457065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
    Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA
    Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
    Morris TA; DeLorenzo RJ; Tombes RM
    Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
    Greider C; Chattopadhyay A; Parkhurst C; Yang E
    Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
    Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
    Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.